ÂÜÀòÂÒÂ×

Padma Priya Togarrati, Ph.D., RAPS has a diverse range of work experience spanning from 2010 to the present. Padma Priya is currently a Senior Scientist 2 (Process Sciences and Analytics) at Adicet Bio, Inc, a position they have held since February 2023. Prior to that, they worked at Ambys Medicines from March 2022 to November 2022 as a Lead Senior Scientist [Bioanalytical], where they were responsible for developing analytical methods and strategies for the allogeneic hepatocyte drug product. Padma Priya also collaborated with CROs and provided regulatory recommendations.

Before their time at Ambys Medicines, Togarrati was the Team Lead, Cell Biology at Earli Inc. from September 2021 to March 2022. From March 2021 to August 2021, they worked at Kriya Therapeutics as a Scientist II in Translational Sciences. Togarrati also served as a Cell Line Development Scientist at Eat JUST, Inc. from June 2019 to December 2020, where they focused on developing cell lines.

Their experience also includes working at the Vitalant Research Institute as a Staff Scientist I from January 2014 to June 2019. Padma Priya conducted research related to their role and authored scientific reports. Togarrati was a Postdoctoral Fellow at UCSF from January 2013 to December 2013, and a Postdoctoral Fellow at the University of Wisconsin-Madison from October 2010 to December 2012. During their time at the University of Wisconsin-Madison, they worked on projects involving the identification of hemogenic endothelial cells and the development of a cell line-based imaging platform.

Padma Priya Togarrati, Ph.D., RAPS has a Master of Science (MS) degree in Biochemistry from Devi Ahilya Vishwavidyalaya. Padma Priya also holds a Ph.D. in Medical Genetics from Sanjay Gandhi Postgraduate Institute of Medical Sciences. In addition to their academic qualifications, Padma has obtained certifications in Regulatory Affairs from the Regulatory Affairs Professionals Society (RAPS). Padma Priya holds a Regulatory Affairs Certificate in Medical Devices as well as a Regulatory Affairs Certificate in Pharmaceuticals from RAPS. The specific months and years when these certifications were obtained are not provided in the given information.